SIBO Breath Test: How to Prepare and Interpret Results

A SIBO breath test measures hydrogen and methane in your exhaled breath after you drink a sugar solution, and it is the most widely used noninvasive method for diagnosing small intestinal bacterial overgrowth. The test is simple in concept: bacteria that have colonized the small intestine ferment the sugar before it reaches the colon, producing gases that cross into the bloodstream and are exhaled through the lungs. But the test’s accuracy, preparation requirements, and interpretation are less straightforward than many patients expect, and a significant debate among gastroenterologists questions whether breath testing should remain the go-to diagnostic tool at all.

How the Test Works

You fast overnight, then drink a measured dose of either glucose or lactulose dissolved in water. Over the next two to three hours, you breathe into collection tubes or a handheld device at regular intervals, typically every 15 or 20 minutes. The samples are analyzed for hydrogen and methane concentrations. A rapid early rise in either gas suggests bacteria are fermenting the substrate in the small intestine rather than letting it pass through to the colon, where fermentation normally occurs.¹

The two substrates behave differently. Glucose is absorbed quickly in the upper small intestine, so it mostly detects overgrowth in that region. Lactulose is not absorbed by humans at all and travels the entire length of the small bowel, which lets it pick up bacteria farther down but also means it always reaches the colon and gets fermented there, making it harder to distinguish small-bowel fermentation from normal colonic fermentation. This distinction matters a lot for interpretation.

What Counts as a Positive Result

The 2017 North American Consensus, the most widely referenced standard in clinical practice, defines a positive test for SIBO as a rise of 20 parts per million or more in hydrogen above baseline within the first 90 minutes. For methane, a level of 10 ppm or more at any point during the test is considered positive. The consensus also clarified that you do not need to see two distinct peaks on the breath curve; a single early rise is sufficient.²

These cutoffs were chosen to balance sensitivity and specificity, but they are not universally agreed upon. Some labs use different thresholds, and clinicians in Europe and Asia sometimes apply slightly different criteria. If you receive results from a commercial lab, it is worth checking which cutoffs were used, because a “negative” result at one lab might have been called “positive” under a different protocol.

Accuracy and Its Limits

The gold-standard comparison for SIBO is direct sampling: threading a tube into the small intestine (jejunal aspiration) and culturing the fluid to count bacteria. Breath tests are compared against this standard, and the results are humbling. A systematic review with meta-analysis found that the lactulose breath test had a pooled sensitivity of about 42% and specificity of about 71%, while the glucose breath test performed somewhat better at roughly 55% sensitivity and 83% specificity.³ In plain terms, the glucose breath test correctly identifies just over half of people who actually have SIBO and correctly rules it out in about four out of five who don’t.

A smaller head-to-head comparison of 40 subjects found that the glucose breath test showed good agreement with jejunal culture, while the lactulose test showed poor agreement. In that study, sensitivity for the lactulose and glucose tests was about 86% and 71%, respectively, with the glucose test achieving notably higher specificity at 92% compared to 77% for lactulose.⁴ These numbers jump around from study to study, but the overall picture is consistent: glucose outperforms lactulose in specificity, and neither test is as reliable as clinicians or patients would like.

A false negative means you have SIBO but the test misses it. A false positive means the test says you have SIBO when you don’t. Both happen regularly, and this is one reason some practitioners treat based on symptoms and clinical context rather than relying on the breath test alone.

The Controversy You Should Know About

A joint clinical practice update endorsed by both the European Society of Neurogastroenterology and Motility and its American counterpart took a sharp position: the hypothesis that increased small-intestine bacteria account for symptoms in conditions like irritable bowel syndrome remains unproven after more than two decades, and breath testing for SIBO is unreliable and unvalidated. The authors argued that reliance on breath tests has led to widespread overuse of antibiotics, and they called for the hypothesis to be rejected in its current form.

This is a minority position, but it comes from respected researchers and highlights genuine weaknesses. The gold-standard jejunal aspiration is invasive and rarely performed, so most studies validating breath tests are circular, comparing one imperfect test against another. The fact that many patients with IBS test positive for SIBO does not prove that the bacteria are causing their symptoms. That said, there is also real evidence that treating a positive breath test with antibiotics leads to symptom improvement in a meaningful subset of patients, which is the pragmatic argument for continuing to use the test.

The Three Gases and What They Tell You

Traditional breath tests measured only hydrogen. Most modern tests measure hydrogen and methane, and a growing number of clinics now test for a third gas: hydrogen sulfide. Each gas is associated with distinct patterns of symptoms and different microbial populations.

Hydrogen

A hydrogen-dominant result is the most common positive finding. Excess hydrogen in the small intestine is produced by a variety of bacterial species and is generally associated with diarrhea-predominant symptoms, bloating, and abdominal discomfort. The original consensus criteria were built around hydrogen measurement, and it remains the most studied gas in breath testing.

Methane and Intestinal Methanogen Overgrowth

Methane on a breath test is not produced by bacteria at all. It comes from archaea, a distinct type of microorganism, primarily a species called Methanobrevibacter smithii. The clinical profile is different: methane is strongly linked to constipation rather than diarrhea. Studies have found that stool counts of M. smithii are dramatically higher in people who produce methane on breath tests, and that there is a clear threshold: a minimum of about 420,000 copies per gram of stool was needed to produce a positive methane breath test.⁵ Separate research confirmed that people with constipation-predominant IBS carry significantly more M. smithii than healthy controls or those with diarrhea-predominant IBS, and that M. smithii load inversely correlated with stool frequency: the more archaea, the fewer bowel movements per day.⁶

Because archaea are not bacteria, elevated methane is increasingly referred to as intestinal methanogen overgrowth (IMO) rather than SIBO. This matters practically because archaea do not respond to the same antibiotics as bacteria. Rifaximin alone, the standard treatment for hydrogen-dominant SIBO, tends to be less effective against methane; clinicians often add a second agent like neomycin or metronidazole when targeting methane producers.

Hydrogen Sulfide

Hydrogen sulfide measurement is newer and less standardized, but early data is compelling. A large real-world study found that higher breath hydrogen sulfide levels correlated with more severe diarrhea, more urgent bowel movements, and more severe abdominal pain.⁷ Research into the underlying microbial profiles found that people with diarrhea-predominant IBS had higher breath hydrogen sulfide that correlated with a greater abundance of sulfide-producing bacteria, including Fusobacterium and Desulfovibrio species.⁸ If your two-gas breath test comes back negative but you still have severe diarrhea and bloating, a three-gas test that includes hydrogen sulfide might pick up what was missed.

Why Preparation Matters More Than You Think

Most testing protocols ask you to follow a restrictive diet the day before the test, avoiding high-fiber foods, beans, dairy, and other fermentable carbohydrates, and then fast overnight. Many patients treat this as optional or follow it loosely, which is a mistake. A study directly comparing outcomes in patients who followed a strict preparatory diet versus those who did not found that hydrogen and methane baseline values were significantly higher without the diet. The positive rate for methane was 43% in the group that ate normally the day before, compared to 28% in the group that followed the restricted diet, and hydrogen positives dropped from 18% to 12%.⁹

In other words, eating a bowl of lentil soup the night before your test could push your baseline gas levels high enough to produce a false positive. The prep diet is not about comfort; it directly affects whether the results mean anything. If your clinic did not give you specific dietary instructions, ask. If you ate a high-fiber meal within 24 hours of the test and got a borderline positive, the result is questionable.

Beyond diet, other preparation factors matter. Antibiotics taken within the past few weeks can suppress bacterial populations and produce a false negative. Prokinetic medications, laxatives, and probiotics can also shift results. Smoking immediately before the test raises baseline hydrogen. Physical exercise increases gut transit, which can affect timing. The test is simple to administer, but getting a meaningful result requires following a fairly specific preparation protocol.¹⁰

Who Is Most Likely to Have SIBO

Several conditions make SIBO more likely, and understanding your risk factors can help you and your doctor decide whether to test in the first place. Anything that slows motility in the small intestine creates an environment where bacteria accumulate. This includes conditions like scleroderma, diabetic gastroparesis, post-surgical adhesions, and chronic opioid use. The small intestine normally clears bacteria with a sweeping wave of contractions between meals, and when that mechanism fails, overgrowth follows.¹¹

Proton pump inhibitor use is another well-studied risk factor. A meta-analysis found that PPI users had roughly 70% higher odds of developing SIBO than non-users.¹² One study found that SIBO was present in half of long-term PPI users, compared to about 25% of IBS patients not on PPIs and 6% of healthy controls.¹³ Stomach acid is a natural barrier against bacteria, and suppressing it long-term lets more organisms survive the transit into the small bowel. Older age compounds the issue: a study of elderly patients on acid-suppressing medications found that age itself was independently associated with a positive glucose breath test result.¹⁴

Other common risk factors include prior abdominal surgery (especially procedures that create blind loops or alter anatomy), celiac disease, chronic pancreatitis, and immune deficiency. If you have one or more of these risk factors and are experiencing bloating, gas, diarrhea, or unexplained weight loss, a breath test is a reasonable diagnostic step even given its limitations.

What Happens After a Positive Test

A positive breath test typically leads to a course of antibiotics, most commonly rifaximin for hydrogen-dominant SIBO. The practical question for patients is whether normalizing the breath test actually translates into feeling better. A systematic review and meta-analysis of treatment studies found that among patients whose breath test normalized after antibiotics, about 80% reported symptom improvement. Among patients who still tested positive after treatment, only about 28% felt better. The difference was striking: people whose breath test normalized were nearly three times more likely to improve symptomatically.¹⁵

This data is reassuring in one sense: if the test normalizes after treatment, there is a good chance you will feel better. But it also highlights a frustration. SIBO recurrence is common, particularly when the underlying cause, such as impaired motility or continued PPI use, is not addressed. Many patients go through multiple rounds of testing and treatment, which is where the debate about antibiotic overuse becomes practical.

At-Home Testing and New Technologies

The traditional breath test is done in a clinic or gastroenterologist’s office, but at-home kits have become popular. These usually involve breathing into sealed tubes at timed intervals and mailing them to a lab. A pilot study evaluating one handheld app-connected device found a strong correlation with standard mail-in kit results for hydrogen measurement.¹⁶ At-home tests can be convenient, especially for people who do not live near a gastroenterology practice, but they rely on you following the prep and timing protocol exactly without clinical oversight. If your timing is off by 20 minutes or you forgot to fast, the results may not be interpretable.

A more fundamental rethink of SIBO diagnostics involves ingestible gas-sensing capsules. Instead of measuring gas that diffuses through the bloodstream and into the lungs, these capsules measure fermentation gases directly inside the gut. An interim analysis presented at Digestive Disease Week found that the capsule achieved a diagnostic accuracy of 72% compared to 64% for standard hydrogen and methane breath tests, with notably better sensitivity: 67% versus 16%.¹⁷ A separate pilot trial in healthy subjects found that the capsule measured hydrogen concentrations over 3,000 times higher than what appeared in breath, giving it a much better signal-to-noise ratio and detecting fermentation from doses of substrate too small for breath tests to pick up.¹⁸

These capsules are still in development and not commercially available for routine SIBO diagnosis, but they illustrate why the current breath test frustrates researchers: measuring gas in exhaled breath is an indirect, lossy signal. Much of the hydrogen produced in the gut never makes it to the lungs, and the timing of peaks in breath gas does not always match what is happening in the intestine in real time. A device that sits in the gut and measures directly sidesteps most of these problems. Whether gas-sensing capsules will eventually replace the breath test depends on clinical trials still underway, but the early numbers suggest a meaningful improvement in sensitivity, which is the breath test’s weakest point.

Bariatric Surgery and Altered Anatomy

If you have had gastric bypass, a Billroth procedure, or another surgery that rearranges the GI tract, breath test interpretation gets more complicated. Surgical blind loops, shortened intestinal segments, and altered transit times can all change how substrate moves through the gut and when gas appears in breath. The standard 90-minute interpretation window assumes normal anatomy; if your anatomy is anything but normal, the usual cutoffs may not apply. Breath tests are still used after bariatric surgery, but the literature is largely limited to review-level summaries rather than large prospective studies validating specific cutoffs for post-surgical patients. If you have had abdominal surgery and your doctor orders a breath test, it is reasonable to ask how the results will be interpreted given your altered anatomy.